Consistency Analysis of Programmed Death-Ligand 1 Expression between Primary and Metastatic Non-Small Cell Lung Cancer: A Retrospective Study

Background: Programmed death-ligand 1 (PD-L1) expression in non-small cell lung cancer (NSCLC) is considered as a predictive biomarker of anti-PD-1/PD-L1 cancer therapies. However, the correlation of PD-L1 expression status between the primary and paired metastatic NSCLC is still not clear. The curr...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Luqiao, Luo, Xinlan, Chen, Wendan, Liang, Chunyan, Yao, Su, Huang, Weihong, Liu, Chao, Ge, Yan, Lin, Xingtao, Li, Zhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6959024/
https://www.ncbi.nlm.nih.gov/pubmed/31949500
http://dx.doi.org/10.7150/jca.34793

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6959024/
https://www.ncbi.nlm.nih.gov/pubmed/31949500
http://dx.doi.org/10.7150/jca.34793

Ejemplares similares